Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecas211915-06-9

211915-06-9

211915-06-9 structural image
Product Name: Dabigatran etexilate
Formula: C34H41N7O5
Inquiry

PRODUCT INTRODUCTION

Description

In March 2008, the European Commission granted marketing authorization for dabigatran etexilate (Pradaxa; Boehringer Ingelheim), a direct thrombin inhibitor, for the prevention of venous thromboembolic events in patients who have undergone total hip- or knee-replacement surgery.

RELATED SUPPLIERS

KARPSCHEM LABORATORIES PVT. LTD.

1Y
product:211915-06-9 Dabigatran Etexilate N-[[2-[[[4- [[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methy l]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β- Alanine Ethyl Ester 96%

Lee Pharma Ltd

1Y
product:211915-06-9 98%

Nosch Labs Pvt Ltd

1Y
product:Dabigatran etexilate 99%

HRV Global Life Sciences

1Y
product:Dabigatran etexilate 211915-06-9 99%

Afton Pharma

1Y
product:211915-06-9 Dabigatran etexilate 98%

Chempifine Chemicals

1Y
product:211915-06-9 98%

Dr. ASCRO Bio Sciences Private Limited

1Y
product:Dabigatran etexilate 98%

Rivashaa Agrotech Biopharma Pvt. Ltd.

1Y
product:Dabigatran etexilate 211915-06-9 98%

Cubane Pharmaceuticals LLP

1Y
product:211915-06-9 Dabigatran etexilate 99%
All suppliers(13)